SCHEMBL4777644

SCHEMBL4777644

CS(=O)(=O)N(Cc1cccc(Cl)c1Cl)c1ccc(CO)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.45
LMNA P02545 4/20 0.43
POLB P06746 2/20 0.43
ALDH1A1 P00352 1/20 0.42
RECQL P46063 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPT P10636 2/20 0.39
NR1I2 O75469 1/20 0.38
PTPN1 P18031 1/20 0.37
PTPN6 P29350 1/20 0.37
PTPN11 Q06124 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RORC P51449 1/20 0.37
NR1H4 Q96RI1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4775060 0.90 GAA (0.39) GAALMNAPOLBALDH1A1RECQL
SCHEMBL4775063 0.88 GAA (0.40) GAALMNAPOLBALDH1A1MEN1
SCHEMBL4772377 0.88 PNMT (0.47) GAALMNAPOLBALDH1A1RECQL
SCHEMBL4771201 0.86 LMNA (0.50) GAALMNAPOLBALDH1A1RECQL
SCHEMBL4777553 0.85 ALDH1A1 (0.49) GAALMNAPOLBALDH1A1RECQL
SCHEMBL4775349 0.85 LMNA (0.41) GAALMNAPOLBALDH1A1RECQL
SCHEMBL4769629 0.83 GAA (0.52) GAALMNAPOLBALDH1A1MEN1
SCHEMBL4767920 0.83 NR1H4 (0.50) GAALMNAALDH1A1MEN1KMT2A
SCHEMBL4773540 0.83 GAA (0.43) GAALMNAPOLBALDH1A1RECQL
SCHEMBL4769594 0.82 GAA (0.48) GAALMNAPOLBALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP claimed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US claimed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO claimed
EP-1942888-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2008-07-16 EP disclosed
US-20070135435-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INCORPORATED 2007-06-14 US disclosed
WO-2007056078-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2007-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135435-A1 Certain chemical entities, compositions, and methods KIF5B, KIF2C, PLK1 GAA 466/4885LMNA 1022/4885POLB 292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.